Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
25
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Clague Laura | Chief Financial Officer | 42 | $0 | $1.13M | 2020-11-25 |
| ROTE WILLIAM E. | Senior Vice President, R&D | 38 | $0 | $567.0K | 2020-11-16 |
| REED ELIZABETH E | SVP, GC & Corporate Secretary | 39 | $0 | $510.1K | 2020-11-16 |
| ASELAGE STEVE | President and COO | 61 | $176.4K | $3.46M | 2020-11-06 |
| Heerma Peter | Chief Commercial Officer | 7 | $0 | $83.7K | 2020-10-05 |
| Rosenberg Noah L. | Chief Medical Officer | 19 | $0 | $131.9K | 2020-09-23 |
| Dube Eric M | Chief Executive Officer | 14 | $0 | $317.4K | 2020-09-21 |
| Baynes Roy D. | Director | 10 | $0 | $0 | 2020-05-15 |
| Poole Sandra | Director | 4 | $0 | $0 | 2020-05-15 |
| Meckler Jeffrey A | Director | 17 | $350.1K | $0 | 2020-05-15 |
| Orwin John A | Director | 8 | $0 | $0 | 2020-05-15 |
| Squarer Ron | Director | 8 | $0 | $0 | 2020-05-15 |
| Coughlin Timothy P | Director | 12 | $0 | $0 | 2020-05-15 |
| LYONS GARY A | Director | 14 | $0 | $0 | 2020-05-15 |
| Bruhn Suzanne Louise | Director | 2 | $0 | $0 | 2020-04-08 |
| McFarlane Neil F. | Chief Operating Officer | 16 | $0 | $552.6K | 2019-05-16 |
| KOZARICH JOHN W | Director | 10 | $0 | $0 | 2019-05-08 |
| Shih Alvin | EVP of Research & Development | 10 | $0 | $1.69M | 2016-09-01 |
| Golding Cornelius E | Director | 9 | $40.5K | $0 | 2016-05-18 |
| VALEUR JENSEN MARGARET E | General Counsel | 5 | $0 | $1.02M | 2016-02-01 |
| Plotkin Horacio | Chief Medical Officer | 7 | $9.9K | $99.7K | 2014-12-12 |
| Richardson Steven Gary | Director | 7 | $76.1K | $0 | 2014-11-21 |
| Shkreli Martin | Other | 63 | $5.56M | $14.79M | 2014-11-21 |
| Paley Jeffrey | Director | 2 | $0 | $245.6K | 2014-08-14 |
| PANOFF MARC L | Chief Financial Officer | 3 | $5.0K | $0 | 2014-02-24 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Clague Laura | Chief Financial Officer | S Sale | 2020-11-25 | 2020-11-25 | 3,750 | $22.72 | $85.2K | 19,473 | SEC↗ |
| Clague Laura | Chief Financial Officer | S Sale | 2020-11-24 | 2020-11-25 | 3,750 | $23.86 | $89.5K | 23,223 | SEC↗ |
| Clague Laura | Chief Financial Officer | A Award | 2020-11-23 | 2020-11-25 | 7,500 | — | $0 | 26,973 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | S Sale | 2020-11-16 | 2020-11-17 | 2,500 | $23.98 | $60.0K | 25,431 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | S Sale | 2020-11-16 | 2020-11-17 | 2,500 | $23.96 | $59.9K | 24,086 | SEC↗ |
| Clague Laura | Chief Financial Officer | S Sale | 2020-11-16 | 2020-11-17 | 7,500 | $23.98 | $179.8K | 19,473 | SEC↗ |
| Clague Laura | Chief Financial Officer | S Sale | 2020-11-13 | 2020-11-13 | 7,500 | $23.61 | $177.1K | 26,973 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | S Sale | 2020-11-13 | 2020-11-13 | 2,500 | $23.62 | $59.0K | 26,586 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | S Sale | 2020-11-13 | 2020-11-13 | 2,500 | $23.62 | $59.0K | 27,931 | SEC↗ |
| Clague Laura | Chief Financial Officer | A Award | 2020-11-11 | 2020-11-13 | 15,000 | — | $0 | 34,473 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | A Award | 2020-11-11 | 2020-11-13 | 5,000 | — | $0 | 29,086 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | A Award | 2020-11-11 | 2020-11-13 | 5,000 | — | $0 | 30,431 | SEC↗ |
| ASELAGE STEVE | Director | S Sale | 2020-11-06 | 2020-11-06 | 20,625 | $23.00 | $474.4K | 213,107 | SEC↗ |
| ASELAGE STEVE | Director | S Sale | 2020-11-05 | 2020-11-06 | 2,500 | $21.26 | $53.2K | 233,732 | SEC↗ |
| Heerma Peter | Chief Commercial Officer | S Sale | 2020-10-05 | 2020-10-05 | 2,188 | $19.35 | $42.3K | 42,329 | SEC↗ |
| Heerma Peter | Chief Commercial Officer | S Sale | 2020-10-02 | 2020-10-05 | 2,188 | $18.90 | $41.4K | 44,517 | SEC↗ |
| Clague Laura | Chief Financial Officer | S Sale | 2020-09-23 | 2020-09-23 | 1,500 | $18.48 | $27.7K | 19,473 | SEC↗ |
| Rosenberg Noah L. | Chief Medical Officer | S Sale | 2020-09-23 | 2020-09-23 | 750 | $18.48 | $13.9K | 27,555 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | S Sale | 2020-09-23 | 2020-09-23 | 1,500 | $18.48 | $27.7K | 25,431 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | S Sale | 2020-09-23 | 2020-09-23 | 1,500 | $18.48 | $27.7K | 24,086 | SEC↗ |
| Clague Laura | Chief Financial Officer | S Sale | 2020-09-22 | 2020-09-22 | 1,500 | $18.59 | $27.9K | 20,973 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | S Sale | 2020-09-22 | 2020-09-22 | 1,500 | $18.59 | $27.9K | 26,931 | SEC↗ |
| Rosenberg Noah L. | Chief Medical Officer | S Sale | 2020-09-22 | 2020-09-22 | 750 | $18.59 | $13.9K | 28,305 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | S Sale | 2020-09-22 | 2020-09-22 | 1,500 | $18.59 | $27.9K | 25,586 | SEC↗ |
| Dube Eric M | Chief Executive Officer | S Sale | 2020-09-21 | 2020-09-22 | 9,240 | $19.28 | $178.1K | 96,260 | SEC↗ |
| Dube Eric M | Chief Executive Officer | S Sale | 2020-09-21 | 2020-09-22 | 1,565 | $19.29 | $30.2K | 94,695 | SEC↗ |
| Dube Eric M | Chief Executive Officer | A Award | 2020-09-18 | 2020-09-22 | 3,000 | — | $0 | 105,500 | SEC↗ |
| Dube Eric M | Chief Executive Officer | A Award | 2020-09-18 | 2020-09-22 | 25,000 | — | $0 | 102,500 | SEC↗ |
| Clague Laura | Chief Financial Officer | A Award | 2020-09-18 | 2020-09-22 | 3,000 | — | $0 | 22,473 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | A Award | 2020-09-18 | 2020-09-22 | 3,000 | — | $0 | 28,431 | SEC↗ |
| Rosenberg Noah L. | Chief Medical Officer | A Award | 2020-09-18 | 2020-09-22 | 3,000 | — | $0 | 29,055 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | A Award | 2020-09-18 | 2020-09-22 | 3,000 | — | $0 | 27,086 | SEC↗ |
| ASELAGE STEVE | Director | S Sale | 2020-08-05 | 2020-08-06 | 2,500 | $19.68 | $49.2K | 236,232 | SEC↗ |
| Rosenberg Noah L. | Chief Medical Officer | S Sale | 2020-07-28 | 2020-07-30 | 870 | $20.49 | $17.8K | 26,055 | SEC↗ |
| ASELAGE STEVE | Director | S Sale | 2020-06-25 | 2020-06-29 | 10,000 | $20.00 | $200.0K | 238,732 | SEC↗ |
| Baynes Roy D. | Director | A Award deriv | 2020-05-15 | 2020-05-19 | 9,000 | — | $0 | 9,000 | SEC↗ |
| ASELAGE STEVE | Director | A Award deriv | 2020-05-15 | 2020-05-19 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Poole Sandra | Director | A Award deriv | 2020-05-15 | 2020-05-19 | 9,000 | — | $0 | 9,000 | SEC↗ |
| COUGHLIN TIMOTHY | Director | A Award deriv | 2020-05-15 | 2020-05-19 | 9,000 | — | $0 | 9,000 | SEC↗ |
| LYONS GARY A | Director | A Award deriv | 2020-05-15 | 2020-05-19 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Meckler Jeffrey A | Director | A Award deriv | 2020-05-15 | 2020-05-19 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Orwin John A | Director | A Award deriv | 2020-05-15 | 2020-05-19 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Squarer Ron | Director | A Award deriv | 2020-05-15 | 2020-05-19 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Baynes Roy D. | Director | A Award | 2020-05-15 | 2020-05-19 | 3,000 | — | $0 | 14,000 | SEC↗ |
| ASELAGE STEVE | Director | A Award | 2020-05-15 | 2020-05-19 | 3,000 | — | $0 | 248,732 | SEC↗ |
| Poole Sandra | Director | A Award | 2020-05-15 | 2020-05-19 | 3,000 | — | $0 | 6,500 | SEC↗ |
| COUGHLIN TIMOTHY | Director | A Award | 2020-05-15 | 2020-05-19 | 3,000 | — | $0 | 32,000 | SEC↗ |
| LYONS GARY A | Director | A Award | 2020-05-15 | 2020-05-19 | 3,000 | — | $0 | 34,000 | SEC↗ |
| Meckler Jeffrey A | Director | A Award | 2020-05-15 | 2020-05-19 | 3,000 | — | $0 | 64,000 | SEC↗ |
| Orwin John A | Director | A Award | 2020-05-15 | 2020-05-19 | 3,000 | — | $0 | 11,875 | SEC↗ |
| Squarer Ron | Director | A Award | 2020-05-15 | 2020-05-19 | 3,000 | — | $0 | 11,875 | SEC↗ |
| ASELAGE STEVE | Director | S Sale | 2020-05-14 | 2020-05-14 | 3,062 | $15.09 | $46.2K | 245,732 | SEC↗ |
| ASELAGE STEVE | Director | S Sale | 2020-05-13 | 2020-05-14 | 4,063 | $16.41 | $66.7K | 248,794 | SEC↗ |
| Clague Laura | Chief Financial Officer | S Sale | 2020-05-12 | 2020-05-13 | 527 | $16.98 | $8.9K | 19,473 | SEC↗ |
| Clague Laura | Chief Financial Officer | S Sale | 2020-05-12 | 2020-05-13 | 1,250 | $17.16 | $21.4K | 20,000 | SEC↗ |
| Rosenberg Noah L. | Chief Medical Officer | S Sale | 2020-05-12 | 2020-05-13 | 527 | $16.98 | $8.9K | 26,728 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | S Sale | 2020-05-12 | 2020-05-13 | 527 | $16.98 | $8.9K | 23,494 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | S Sale | 2020-05-12 | 2020-05-13 | 812 | $17.16 | $13.9K | 24,021 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | S Sale | 2020-05-12 | 2020-05-13 | 527 | $16.98 | $8.9K | 25,431 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | S Sale | 2020-05-12 | 2020-05-13 | 525 | $17.16 | $9.0K | 25,958 | SEC↗ |
| ASELAGE STEVE | Director | S Sale | 2020-05-12 | 2020-05-14 | 1,000 | $17.16 | $17.2K | 252,857 | SEC↗ |
| Clague Laura | Chief Financial Officer | S Sale | 2020-05-11 | 2020-05-13 | 1,250 | $14.95 | $18.7K | 21,250 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | S Sale | 2020-05-11 | 2020-05-13 | 813 | $14.95 | $12.2K | 24,833 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | S Sale | 2020-05-11 | 2020-05-13 | 525 | $14.95 | $7.8K | 26,483 | SEC↗ |
| ASELAGE STEVE | Director | S Sale | 2020-05-05 | 2020-05-06 | 2,500 | $15.88 | $39.7K | 253,857 | SEC↗ |
| Bruhn Suzanne Louise | Director | A Award deriv | 2020-04-08 | 2020-04-09 | 15,750 | — | $0 | 15,750 | SEC↗ |
| Bruhn Suzanne Louise | Director | A Award | 2020-04-08 | 2020-04-09 | 5,250 | — | $0 | 5,250 | SEC↗ |
| Clague Laura | Chief Financial Officer | S Sale | 2020-03-10 | 2020-03-12 | 4,000 | $15.02 | $60.1K | 22,500 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | S Sale | 2020-03-10 | 2020-03-12 | 3,500 | $15.02 | $52.6K | 27,008 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | S Sale | 2020-03-10 | 2020-03-12 | 3,250 | $14.87 | $48.3K | 25,646 | SEC↗ |
| ASELAGE STEVE | Director | S Sale | 2020-03-05 | 2020-03-09 | 4,359 | $15.36 | $67.0K | 256,357 | SEC↗ |
| ASELAGE STEVE | Director | A Award | 2020-03-05 | 2020-03-09 | 12,250 | — | $0 | 260,716 | SEC↗ |
| Rosenberg Noah L. | Chief Medical Officer | S Sale | 2020-03-05 | 2020-03-09 | 1,790 | $15.36 | $27.5K | 27,255 | SEC↗ |
| Rosenberg Noah L. | Chief Medical Officer | A Award | 2020-03-05 | 2020-03-09 | 5,000 | — | $0 | 29,045 | SEC↗ |
| Clague Laura | Chief Financial Officer | A Award | 2020-03-05 | 2020-03-09 | 4,000 | — | $0 | 26,500 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | A Award | 2020-03-05 | 2020-03-09 | 3,500 | — | $0 | 30,508 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | A Award | 2020-03-05 | 2020-03-09 | 3,250 | — | $0 | 28,896 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | S Sale | 2020-02-18 | 2020-02-19 | 1,250 | $16.55 | $20.7K | 25,646 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | S Sale | 2020-02-14 | 2020-02-19 | 1,250 | $16.72 | $20.9K | 26,896 | SEC↗ |
| ASELAGE STEVE | Director | S Sale | 2020-02-05 | 2020-02-07 | 2,500 | $16.62 | $41.5K | 248,466 | SEC↗ |
| Dube Eric M | Chief Executive Officer | A Award deriv | 2020-01-31 | 2020-01-31 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Dube Eric M | Chief Executive Officer | A Award deriv | 2020-01-31 | 2020-01-31 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Dube Eric M | Chief Executive Officer | A Award deriv | 2020-01-31 | 2020-01-31 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Clague Laura | Chief Financial Officer | A Award deriv | 2020-01-31 | 2020-01-31 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Clague Laura | Chief Financial Officer | A Award deriv | 2020-01-31 | 2020-01-31 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Clague Laura | Chief Financial Officer | A Award deriv | 2020-01-31 | 2020-01-31 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Heerma Peter | Chief Commercial Officer | A Award deriv | 2020-01-31 | 2020-01-31 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Heerma Peter | Chief Commercial Officer | A Award deriv | 2020-01-31 | 2020-01-31 | 55,000 | — | $0 | 55,000 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | A Award deriv | 2020-01-31 | 2020-01-31 | 10,000 | — | $0 | 10,000 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | A Award deriv | 2020-01-31 | 2020-01-31 | 9,000 | — | $0 | 9,000 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | A Award deriv | 2020-01-31 | 2020-01-31 | 55,000 | — | $0 | 55,000 | SEC↗ |
| Rosenberg Noah L. | Chief Medical Officer | A Award deriv | 2020-01-31 | 2020-01-31 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Rosenberg Noah L. | Chief Medical Officer | A Award deriv | 2020-01-31 | 2020-01-31 | 9,000 | — | $0 | 9,000 | SEC↗ |
| Rosenberg Noah L. | Chief Medical Officer | A Award deriv | 2020-01-31 | 2020-01-31 | 55,000 | — | $0 | 55,000 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | A Award deriv | 2020-01-31 | 2020-01-31 | 9,000 | — | $0 | 9,000 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | A Award deriv | 2020-01-31 | 2020-01-31 | 55,000 | — | $0 | 55,000 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | A Award deriv | 2020-01-31 | 2020-01-31 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Dube Eric M | Chief Executive Officer | A Award | 2020-01-31 | 2020-01-31 | 35,000 | — | $0 | 77,500 | SEC↗ |
| Clague Laura | Chief Financial Officer | A Award | 2020-01-31 | 2020-01-31 | 9,000 | — | $0 | 22,500 | SEC↗ |
| Heerma Peter | Chief Commercial Officer | A Award | 2020-01-31 | 2020-01-31 | 9,000 | — | $0 | 44,000 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | A Award | 2020-01-31 | 2020-01-31 | 9,000 | — | $0 | 27,008 | SEC↗ |
| Rosenberg Noah L. | Chief Medical Officer | A Award | 2020-01-31 | 2020-01-31 | 9,000 | — | $0 | 22,500 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | A Award | 2020-01-31 | 2020-01-31 | 9,000 | — | $0 | 27,185 | SEC↗ |
| Dube Eric M | Chief Executive Officer | S Sale | 2020-01-08 | 2020-01-08 | 3,750 | $15.14 | $56.8K | 42,500 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | S Sale | 2020-01-08 | 2020-01-08 | 750 | $15.14 | $11.4K | 18,008 | SEC↗ |
| Dube Eric M | Chief Executive Officer | S Sale | 2020-01-07 | 2020-01-08 | 3,750 | $13.94 | $52.3K | 46,250 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | S Sale | 2020-01-07 | 2020-01-08 | 750 | $13.94 | $10.5K | 18,758 | SEC↗ |
| ASELAGE STEVE | Director | S Sale | 2019-11-29 | 2019-11-29 | 5,000 | $13.91 | $69.5K | 250,966 | SEC↗ |
| Heerma Peter | Chief Commercial Officer | A Award deriv | 2019-10-01 | 2019-10-02 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Heerma Peter | Chief Commercial Officer | A Award | 2019-10-01 | 2019-10-02 | 35,000 | — | $0 | 35,000 | SEC↗ |
| Rosenberg Noah L. | Chief Medical Officer | S Sale | 2019-07-31 | 2019-07-31 | 1,250 | $20.07 | $25.1K | 13,500 | SEC↗ |
| Rosenberg Noah L. | Chief Medical Officer | S Sale | 2019-07-30 | 2019-07-31 | 1,250 | $19.82 | $24.8K | 14,750 | SEC↗ |
| Clague Laura | Chief Financial Officer | S Sale | 2019-05-16 | 2019-05-16 | 1,250 | $18.71 | $23.4K | 13,500 | SEC↗ |
| McFarlane Neil F. | Chief Operating Officer | S Sale | 2019-05-16 | 2019-05-16 | 984 | $18.71 | $18.4K | 26,988 | SEC↗ |
| ASELAGE STEVE | Director | S Sale | 2019-05-15 | 2019-05-16 | 1,838 | $17.82 | $32.8K | 255,966 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | S Sale | 2019-05-15 | 2019-05-16 | 525 | $17.71 | $9.3K | 19,508 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | S Sale | 2019-05-15 | 2019-05-16 | 812 | $17.76 | $14.4K | 18,185 | SEC↗ |
| Clague Laura | Chief Financial Officer | S Sale | 2019-05-15 | 2019-05-16 | 1,250 | $17.78 | $22.2K | 14,750 | SEC↗ |
| McFarlane Neil F. | Chief Operating Officer | S Sale | 2019-05-15 | 2019-05-16 | 984 | $17.78 | $17.5K | 27,972 | SEC↗ |
| ASELAGE STEVE | Director | S Sale | 2019-05-14 | 2019-05-16 | 1,838 | $17.79 | $32.7K | 257,804 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | S Sale | 2019-05-14 | 2019-05-16 | 525 | $17.75 | $9.3K | 20,033 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | S Sale | 2019-05-14 | 2019-05-16 | 813 | $17.78 | $14.5K | 18,997 | SEC↗ |
| Poole Sandra | Director | A Award deriv | 2019-05-13 | 2019-05-15 | 14,000 | — | $0 | 14,000 | SEC↗ |
| Poole Sandra | Director | A Award | 2019-05-13 | 2019-05-15 | 3,500 | — | $0 | 3,500 | SEC↗ |
| Dube Eric M | Chief Executive Officer | A Award deriv | 2019-05-09 | 2019-05-10 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Clague Laura | Chief Financial Officer | A Award deriv | 2019-05-09 | 2019-05-10 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Clague Laura | Chief Financial Officer | A Award deriv | 2019-05-09 | 2019-05-10 | 6,000 | — | $0 | 6,000 | SEC↗ |
| Rosenberg Noah L. | Chief Medical Officer | A Award deriv | 2019-05-09 | 2019-05-10 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Rosenberg Noah L. | Chief Medical Officer | A Award deriv | 2019-05-09 | 2019-05-10 | 6,000 | — | $0 | 6,000 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | A Award deriv | 2019-05-09 | 2019-05-10 | 40,000 | — | $0 | 40,000 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | A Award deriv | 2019-05-09 | 2019-05-10 | 6,000 | — | $0 | 6,000 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | A Award deriv | 2019-05-09 | 2019-05-10 | 6,000 | — | $0 | 6,000 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | A Award deriv | 2019-05-09 | 2019-05-10 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Clague Laura | Chief Financial Officer | A Award | 2019-05-09 | 2019-05-10 | 6,000 | — | $0 | 16,000 | SEC↗ |
| Rosenberg Noah L. | Chief Medical Officer | A Award | 2019-05-09 | 2019-05-10 | 6,000 | — | $0 | 16,000 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | A Award | 2019-05-09 | 2019-05-10 | 6,000 | — | $0 | 19,810 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | A Award | 2019-05-09 | 2019-05-10 | 6,000 | — | $0 | 20,558 | SEC↗ |
| ASELAGE STEVE | Director | A Award deriv | 2019-05-08 | 2019-05-10 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Baynes Roy D. | Director | A Award deriv | 2019-05-08 | 2019-05-10 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Coughlin Timothy P | Director | A Award deriv | 2019-05-08 | 2019-05-10 | 8,000 | — | $0 | 8,000 | SEC↗ |
| KOZARICH JOHN W | Director | A Award deriv | 2019-05-08 | 2019-05-10 | 8,000 | — | $0 | 8,000 | SEC↗ |
| LYONS GARY A | Director | A Award deriv | 2019-05-08 | 2019-05-10 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Meckler Jeffrey A | Director | A Award deriv | 2019-05-08 | 2019-05-10 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Orwin John A | Director | A Award deriv | 2019-05-08 | 2019-05-10 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Squarer Ron | Director | A Award deriv | 2019-05-08 | 2019-05-10 | 8,000 | — | $0 | 8,000 | SEC↗ |
| ASELAGE STEVE | Director | A Award | 2019-05-08 | 2019-05-10 | 2,000 | — | $0 | 259,642 | SEC↗ |
| Baynes Roy D. | Director | A Award | 2019-05-08 | 2019-05-10 | 2,000 | — | $0 | 11,000 | SEC↗ |
| Coughlin Timothy P | Director | A Award | 2019-05-08 | 2019-05-10 | 2,000 | — | $0 | 29,000 | SEC↗ |
| KOZARICH JOHN W | Director | A Award | 2019-05-08 | 2019-05-10 | 2,000 | — | $0 | 29,000 | SEC↗ |
| LYONS GARY A | Director | A Award | 2019-05-08 | 2019-05-10 | 2,000 | — | $0 | 31,000 | SEC↗ |
| Meckler Jeffrey A | Director | A Award | 2019-05-08 | 2019-05-10 | 2,000 | — | $0 | 61,000 | SEC↗ |
| Orwin John A | Director | A Award | 2019-05-08 | 2019-05-10 | 2,000 | — | $0 | 8,875 | SEC↗ |
| Squarer Ron | Director | A Award | 2019-05-08 | 2019-05-10 | 2,000 | — | $0 | 8,875 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | S Sale | 2019-02-19 | 2019-02-20 | 1,250 | $21.52 | $26.9K | 13,810 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | S Sale | 2019-02-15 | 2019-02-20 | 1,250 | $21.44 | $26.8K | 15,060 | SEC↗ |
| ASELAGE STEVE | Chief Executive Officer | S Sale | 2019-02-12 | 2019-02-13 | 1,065 | $21.50 | $22.9K | 257,642 | SEC↗ |
| Clague Laura | Chief Financial Officer | S Sale | 2019-02-12 | 2019-02-13 | 1,016 | $21.50 | $21.8K | 10,000 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | S Sale | 2019-02-12 | 2019-02-13 | 992 | $21.50 | $21.3K | 16,007 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | S Sale | 2019-02-12 | 2019-02-13 | 884 | $21.50 | $19.0K | 14,558 | SEC↗ |
| ASELAGE STEVE | Chief Executive Officer | S Sale | 2019-02-11 | 2019-02-13 | 1,065 | $21.38 | $22.8K | 258,707 | SEC↗ |
| Clague Laura | Chief Financial Officer | S Sale | 2019-02-11 | 2019-02-13 | 1,017 | $21.38 | $21.7K | 11,016 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | S Sale | 2019-02-11 | 2019-02-13 | 993 | $21.38 | $21.2K | 16,999 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | S Sale | 2019-02-11 | 2019-02-13 | 885 | $21.38 | $18.9K | 15,442 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | S Sale | 2019-01-09 | 2019-01-09 | 750 | $23.82 | $17.9K | 16,327 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | S Sale | 2019-01-08 | 2019-01-09 | 750 | $24.09 | $18.1K | 17,077 | SEC↗ |
| Dube Eric M | Chief Executive Officer | A Award deriv | 2019-01-04 | 2019-01-08 | 400,000 | — | $0 | 400,000 | SEC↗ |
| Dube Eric M | Chief Executive Officer | A Award deriv | 2019-01-04 | 2019-01-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Dube Eric M | Chief Executive Officer | A Award | 2019-01-04 | 2019-01-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Clague Laura | Chief Financial Officer | S Sale | 2018-12-21 | 2018-12-21 | 900 | $22.34 | $20.1K | 12,033 | SEC↗ |
| Clague Laura | Chief Financial Officer | S Sale | 2018-12-21 | 2018-12-21 | 2,850 | $21.67 | $61.8K | 12,933 | SEC↗ |
| ASELAGE STEVE | Chief Executive Officer | S Sale | 2018-12-21 | 2018-12-21 | 5,288 | $21.69 | $114.7K | 260,672 | SEC↗ |
| ASELAGE STEVE | Chief Executive Officer | S Sale | 2018-12-21 | 2018-12-21 | 900 | $22.35 | $20.1K | 259,772 | SEC↗ |
| Clague Laura | Chief Financial Officer | S Sale | 2018-12-20 | 2018-12-21 | 3,750 | $22.08 | $82.8K | 15,783 | SEC↗ |
| ASELAGE STEVE | Chief Executive Officer | S Sale | 2018-12-20 | 2018-12-21 | 6,188 | $21.97 | $136.0K | 265,960 | SEC↗ |
| McFarlane Neil F. | Chief Operating Officer | S Sale | 2018-12-20 | 2018-12-21 | 4,721 | $22.00 | $103.9K | 35,360 | SEC↗ |
| McFarlane Neil F. | Chief Operating Officer | S Sale | 2018-12-20 | 2018-12-21 | 6,404 | $22.56 | $144.5K | 28,956 | SEC↗ |
| ASELAGE STEVE | Chief Executive Officer | A Award | 2018-12-18 | 2018-12-20 | 20,625 | — | $0 | 272,148 | SEC↗ |
| McFarlane Neil F. | Chief Operating Officer | A Award | 2018-12-18 | 2018-12-20 | 11,125 | — | $0 | 40,081 | SEC↗ |
| Clague Laura | Chief Financial Officer | A Award | 2018-12-18 | 2018-12-20 | 7,500 | — | $0 | 19,533 | SEC↗ |
| ASELAGE STEVE | Chief Executive Officer | S Sale | 2018-12-07 | 2018-12-07 | 10 | $24.04 | $240 | 251,523 | SEC↗ |
| ASELAGE STEVE | Chief Executive Officer | G Gift | 2018-11-29 | 2018-12-07 | 1,750 | — | $0 | 251,533 | SEC↗ |
| ASELAGE STEVE | Chief Executive Officer | S Sale | 2018-11-15 | 2018-11-16 | 1,086 | $24.75 | $26.9K | 253,283 | SEC↗ |
| ASELAGE STEVE | Chief Executive Officer | S Sale | 2018-11-15 | 2018-11-16 | 4,464 | $24.21 | $108.1K | 254,369 | SEC↗ |
| Clague Laura | Chief Financial Officer | S Sale | 2018-11-15 | 2018-11-16 | 791 | $24.73 | $19.6K | 12,033 | SEC↗ |
| Clague Laura | Chief Financial Officer | S Sale | 2018-11-15 | 2018-11-16 | 2,959 | $24.20 | $71.6K | 12,824 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | S Sale | 2018-11-15 | 2018-11-16 | 2,188 | $24.25 | $53.1K | 18,304 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | S Sale | 2018-11-15 | 2018-11-16 | 312 | $24.83 | $7.7K | 17,992 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | S Sale | 2018-11-15 | 2018-11-16 | 2,300 | $24.29 | $55.9K | 18,027 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | S Sale | 2018-11-15 | 2018-11-16 | 100 | $24.77 | $2.5K | 17,927 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | S Sale | 2018-11-15 | 2018-11-16 | 100 | $24.81 | $2.5K | 17,827 | SEC↗ |
| ASELAGE STEVE | Chief Executive Officer | S Sale | 2018-11-14 | 2018-11-16 | 600 | $24.58 | $14.7K | 258,833 | SEC↗ |
| ASELAGE STEVE | Chief Executive Officer | S Sale | 2018-11-14 | 2018-11-16 | 4,950 | $23.63 | $117.0K | 259,433 | SEC↗ |
| Clague Laura | Chief Financial Officer | S Sale | 2018-11-14 | 2018-11-16 | 400 | $24.54 | $9.8K | 15,783 | SEC↗ |
| Clague Laura | Chief Financial Officer | S Sale | 2018-11-14 | 2018-11-16 | 3,350 | $23.63 | $79.2K | 16,183 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | S Sale | 2018-11-14 | 2018-11-16 | 300 | $24.57 | $7.4K | 20,492 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | S Sale | 2018-11-14 | 2018-11-16 | 2,200 | $23.62 | $52.0K | 20,792 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | S Sale | 2018-11-14 | 2018-11-16 | 300 | $24.57 | $7.4K | 20,327 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | S Sale | 2018-11-14 | 2018-11-16 | 2,200 | $23.62 | $52.0K | 20,627 | SEC↗ |
| McFarlane Neil F. | Chief Operating Officer | S Sale | 2018-11-14 | 2018-11-16 | 9,000 | $23.63 | $212.7K | 29,476 | SEC↗ |
| McFarlane Neil F. | Chief Operating Officer | S Sale | 2018-11-14 | 2018-11-16 | 1,000 | $24.64 | $24.6K | 28,476 | SEC↗ |
| ASELAGE STEVE | Chief Executive Officer | A Award | 2018-11-09 | 2018-11-14 | 18,500 | — | $0 | 264,383 | SEC↗ |
| Clague Laura | Chief Financial Officer | A Award | 2018-11-09 | 2018-11-14 | 7,500 | — | $0 | 19,533 | SEC↗ |
| McFarlane Neil F. | Chief Operating Officer | A Award | 2018-11-09 | 2018-11-14 | 10,000 | — | $0 | 38,476 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | A Award | 2018-11-09 | 2018-11-14 | 5,000 | — | $0 | 22,827 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | A Award | 2018-11-09 | 2018-11-14 | 5,000 | — | $0 | 22,992 | SEC↗ |
| ASELAGE STEVE | Chief Executive Officer | M Exercise deriv | 2018-08-31 | 2018-08-31 | 12,000 | — | $0 | 0 | SEC↗ |
| ASELAGE STEVE | Chief Executive Officer | S Sale | 2018-08-31 | 2018-08-31 | 12,000 | $32.00 | $384.0K | 245,883 | SEC↗ |
| ASELAGE STEVE | Chief Executive Officer | M Exercise | 2018-08-31 | 2018-08-31 | 12,000 | $8.70 | $104.4K | 257,883 | SEC↗ |
| Rosenberg Noah L. | Chief Medical Officer | A Award deriv | 2018-07-26 | 2018-07-30 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Rosenberg Noah L. | Chief Medical Officer | A Award deriv | 2018-07-26 | 2018-07-30 | 65,000 | — | $0 | 65,000 | SEC↗ |
| Rosenberg Noah L. | Chief Medical Officer | A Award | 2018-07-26 | 2018-07-30 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ASELAGE STEVE | Chief Executive Officer | A Award deriv | 2018-05-10 | 2018-05-14 | 147,000 | — | $0 | 147,000 | SEC↗ |
| ASELAGE STEVE | Chief Executive Officer | A Award deriv | 2018-05-10 | 2018-05-14 | 24,500 | — | $0 | 24,500 | SEC↗ |
| Clague Laura | Chief Financial Officer | A Award deriv | 2018-05-10 | 2018-05-14 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Clague Laura | Chief Financial Officer | A Award deriv | 2018-05-10 | 2018-05-14 | 48,000 | — | $0 | 48,000 | SEC↗ |
| McFarlane Neil F. | Chief Operating Officer | A Award deriv | 2018-05-10 | 2018-05-14 | 63,000 | — | $0 | 63,000 | SEC↗ |
| McFarlane Neil F. | Chief Operating Officer | A Award deriv | 2018-05-10 | 2018-05-14 | 10,500 | — | $0 | 10,500 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | A Award deriv | 2018-05-10 | 2018-05-14 | 7,000 | — | $0 | 7,000 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | A Award deriv | 2018-05-10 | 2018-05-14 | 42,000 | — | $0 | 42,000 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | A Award deriv | 2018-05-10 | 2018-05-14 | 6,500 | — | $0 | 6,500 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | A Award deriv | 2018-05-10 | 2018-05-14 | 39,000 | — | $0 | 39,000 | SEC↗ |
| ASELAGE STEVE | Chief Executive Officer | A Award | 2018-05-10 | 2018-05-14 | 24,500 | — | $0 | 245,883 | SEC↗ |
| Clague Laura | Chief Financial Officer | A Award | 2018-05-10 | 2018-05-14 | 10,000 | — | $0 | 12,033 | SEC↗ |
| McFarlane Neil F. | Chief Operating Officer | A Award | 2018-05-10 | 2018-05-14 | 10,500 | — | $0 | 27,948 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | A Award | 2018-05-10 | 2018-05-14 | 7,000 | — | $0 | 17,827 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | A Award | 2018-05-10 | 2018-05-14 | 6,500 | — | $0 | 17,656 | SEC↗ |
| Meckler Jeffrey A | Director | A Award deriv | 2018-05-09 | 2018-05-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| LYONS GARY A | Director | A Award deriv | 2018-05-09 | 2018-05-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| KOZARICH JOHN W | Director | A Award deriv | 2018-05-09 | 2018-05-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Coughlin Timothy P | Director | A Award deriv | 2018-05-09 | 2018-05-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Baynes Roy D. | Director | A Award deriv | 2018-05-09 | 2018-05-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Squarer Ron | Director | A Award deriv | 2018-05-09 | 2018-05-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Orwin John A | Director | A Award deriv | 2018-05-09 | 2018-05-11 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Meckler Jeffrey A | Director | A Award | 2018-05-09 | 2018-05-11 | 2,500 | — | $0 | 59,000 | SEC↗ |
| LYONS GARY A | Director | A Award | 2018-05-09 | 2018-05-11 | 2,500 | — | $0 | 29,000 | SEC↗ |
| KOZARICH JOHN W | Director | A Award | 2018-05-09 | 2018-05-11 | 2,500 | — | $0 | 27,000 | SEC↗ |
| Coughlin Timothy P | Director | A Award | 2018-05-09 | 2018-05-11 | 2,500 | — | $0 | 27,000 | SEC↗ |
| Baynes Roy D. | Director | A Award | 2018-05-09 | 2018-05-11 | 2,500 | — | $0 | 9,000 | SEC↗ |
| Squarer Ron | Director | A Award | 2018-05-09 | 2018-05-11 | 2,500 | — | $0 | 6,875 | SEC↗ |
| Orwin John A | Director | A Award | 2018-05-09 | 2018-05-11 | 2,500 | — | $0 | 6,875 | SEC↗ |
| ASELAGE STEVE | Chief Executive Officer | M Exercise deriv | 2018-03-07 | 2018-03-08 | 278 | — | $0 | 0 | SEC↗ |
| ASELAGE STEVE | Chief Executive Officer | M Exercise | 2018-03-07 | 2018-03-08 | 278 | $6.00 | $1.7K | 221,383 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | S Sale | 2018-02-14 | 2018-02-16 | 1,034 | $21.50 | $22.2K | 11,156 | SEC↗ |
| ASELAGE STEVE | Chief Executive Officer | A Award | 2018-02-08 | 2018-02-12 | 3,549 | — | $0 | 221,105 | SEC↗ |
| McFarlane Neil F. | Chief Operating Officer | A Award | 2018-02-08 | 2018-02-12 | 2,546 | — | $0 | 17,448 | SEC↗ |
| Clague Laura | Chief Financial Officer | A Award | 2018-02-08 | 2018-02-12 | 2,033 | — | $0 | 2,033 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | A Award | 2018-02-08 | 2018-02-12 | 1,985 | — | $0 | 12,190 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | A Award | 2018-02-08 | 2018-02-12 | 1,769 | — | $0 | 10,827 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | S Sale | 2018-01-05 | 2018-01-08 | 942 | $24.04 | $22.6K | 9,058 | SEC↗ |
| ASELAGE STEVE | Chief Executive Officer | G Gift | 2017-12-26 | 2017-12-27 | 23,000 | — | $0 | 217,556 | SEC↗ |
| ASELAGE STEVE | Chief Executive Officer | G Gift | 2017-12-21 | 2017-12-27 | 5,000 | — | $0 | 240,556 | SEC↗ |
| McFarlane Neil F. | Chief Operating Officer | S Sale | 2017-08-16 | 2017-08-17 | 1,378 | $22.50 | $31.0K | 13,622 | SEC↗ |
| ASELAGE STEVE | Chief Executive Officer | P Buy | 2017-06-14 | 2017-06-14 | 5,000 | $17.85 | $89.3K | 245,556 | SEC↗ |
| ASELAGE STEVE | Chief Executive Officer | A Award deriv | 2017-05-17 | 2017-05-18 | 165,000 | — | $0 | 165,000 | SEC↗ |
| McFarlane Neil F. | Chief Operating Officer | A Award deriv | 2017-05-17 | 2017-05-18 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Clague Laura | Chief Financial Officer | A Award deriv | 2017-05-17 | 2017-05-18 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Coughlin Timothy P | Director | A Award deriv | 2017-05-17 | 2017-05-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Baynes Roy D. | Director | A Award deriv | 2017-05-17 | 2017-05-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Meckler Jeffrey A | Director | A Award deriv | 2017-05-17 | 2017-05-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| LYONS GARY A | Director | A Award deriv | 2017-05-17 | 2017-05-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| KOZARICH JOHN W | Director | A Award deriv | 2017-05-17 | 2017-05-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Coughlin Timothy P | Director | A Award | 2017-05-17 | 2017-05-18 | 2,500 | — | $0 | 24,500 | SEC↗ |
| Baynes Roy D. | Director | A Award | 2017-05-17 | 2017-05-18 | 2,500 | — | $0 | 6,500 | SEC↗ |
| Meckler Jeffrey A | Director | A Award | 2017-05-17 | 2017-05-18 | 2,500 | — | $0 | 56,500 | SEC↗ |
| LYONS GARY A | Director | A Award | 2017-05-17 | 2017-05-18 | 2,500 | — | $0 | 26,500 | SEC↗ |
| KOZARICH JOHN W | Director | A Award | 2017-05-17 | 2017-05-18 | 2,500 | — | $0 | 24,500 | SEC↗ |
| Squarer Ron | Director | A Award deriv | 2017-04-10 | 2017-04-12 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Squarer Ron | Director | A Award | 2017-04-10 | 2017-04-12 | 4,375 | — | $0 | 4,375 | SEC↗ |
| Orwin John A | Director | A Award deriv | 2017-03-23 | 2017-03-27 | 17,500 | — | $0 | 17,500 | SEC↗ |
| Orwin John A | Director | A Award | 2017-03-23 | 2017-03-27 | 4,375 | — | $0 | 4,375 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | A Award deriv | 2017-02-13 | 2017-02-15 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ROTE WILLIAM E. | Senior Vice President, R&D | A Award | 2017-02-13 | 2017-02-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | A Award deriv | 2017-01-04 | 2017-01-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| REED ELIZABETH E | SVP, GC & Corporate Secretar | A Award | 2017-01-04 | 2017-01-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ASELAGE STEVE | Chief Executive Officer | S Sale | 2016-11-22 | 2016-11-23 | 3,200 | $21.30 | $68.2K | 240,556 | SEC↗ |
| ASELAGE STEVE | Chief Executive Officer | G Gift | 2016-11-21 | 2016-11-23 | 57,000 | — | $0 | 248,756 | SEC↗ |
| ASELAGE STEVE | Chief Executive Officer | S Sale | 2016-11-21 | 2016-11-23 | 5,000 | $21.00 | $105.0K | 243,756 | SEC↗ |
| Shih Alvin | EVP of Research & Developmen | S Sale | 2016-09-01 | 2016-09-02 | 8,750 | $16.24 | $142.1K | 158,334 | SEC↗ |
| McFarlane Neil F. | Chief Operating Officer | A Award deriv | 2016-08-15 | 2016-08-15 | 120,000 | — | $0 | 120,000 | SEC↗ |
| McFarlane Neil F. | Chief Operating Officer | A Award | 2016-08-15 | 2016-08-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| Baynes Roy D. | Director | A Award deriv | 2016-07-19 | 2016-07-26 | 16,000 | — | $0 | 16,000 | SEC↗ |
| Baynes Roy D. | Director | A Award | 2016-07-19 | 2016-07-26 | 4,000 | — | $0 | 4,000 | SEC↗ |
| Shih Alvin | EVP of Research & Developmen | S Sale | 2016-06-01 | 2016-06-02 | 8,750 | $17.75 | $155.3K | 167,084 | SEC↗ |
| ASELAGE STEVE | Chief Executive Officer | A Award deriv | 2016-05-19 | 2016-05-23 | 160,000 | — | $0 | 160,000 | SEC↗ |
| Clague Laura | Chief Financial Officer | A Award deriv | 2016-05-19 | 2016-05-23 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Shih Alvin | EVP of Research & Developmen | A Award deriv | 2016-05-19 | 2016-05-23 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Meckler Jeffrey A | Director | A Award deriv | 2016-05-18 | 2016-05-19 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Coughlin Timothy P | Director | A Award deriv | 2016-05-18 | 2016-05-19 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Golding Cornelius E | Director | A Award deriv | 2016-05-18 | 2016-05-19 | 8,000 | — | $0 | 8,000 | SEC↗ |
| KOZARICH JOHN W | Director | A Award deriv | 2016-05-18 | 2016-05-19 | 8,000 | — | $0 | 8,000 | SEC↗ |
| LYONS GARY A | Director | A Award deriv | 2016-05-18 | 2016-05-19 | 8,000 | — | $0 | 8,000 | SEC↗ |
| Meckler Jeffrey A | Director | A Award | 2016-05-18 | 2016-05-19 | 2,000 | — | $0 | 54,000 | SEC↗ |
| Coughlin Timothy P | Director | A Award | 2016-05-18 | 2016-05-19 | 2,000 | — | $0 | 22,000 | SEC↗ |
| Golding Cornelius E | Director | A Award | 2016-05-18 | 2016-05-19 | 2,000 | — | $0 | 29,000 | SEC↗ |
| KOZARICH JOHN W | Director | A Award | 2016-05-18 | 2016-05-19 | 2,000 | — | $0 | 22,000 | SEC↗ |
| LYONS GARY A | Director | A Award | 2016-05-18 | 2016-05-19 | 2,000 | — | $0 | 24,000 | SEC↗ |
| Meckler Jeffrey A | Director | P Buy | 2016-03-04 | 2016-03-07 | 5,000 | $15.31 | $76.5K | 52,000 | SEC↗ |
| Meckler Jeffrey A | Director | P Buy | 2016-03-03 | 2016-03-03 | 10,000 | $14.45 | $144.5K | 47,000 | SEC↗ |
| Shih Alvin | EVP of Research & Developmen | S Sale | 2016-03-01 | 2016-03-01 | 8,750 | $14.35 | $125.6K | 175,834 | SEC↗ |
| VALEUR JENSEN MARGARET E | General Counsel | A Award | 2016-02-01 | 2016-02-02 | 50,000 | — | $0 | 100,000 | SEC↗ |